These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 34023149)

  • 61. [Long Term Efficacy of Antiviral Therapy: Mortality and Incidence of Hepatocellular Carcinoma].
    Lee HW
    Korean J Gastroenterol; 2019 Nov; 74(5):251-257. PubMed ID: 31765553
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Comparison of the on-treatment risks for hepatocellular carcinoma between entecavir and tenofovir: A propensity score matching analysis.
    Ha I; Chung JW; Jang ES; Jeong SH; Kim JW
    J Gastroenterol Hepatol; 2020 Oct; 35(10):1774-1781. PubMed ID: 32154938
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Lower Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir in Patients With Chronic Hepatitis B.
    Liu Z; Sun J; Hou J
    JAMA Oncol; 2019 Jun; 5(6):915. PubMed ID: 31021388
    [No Abstract]   [Full Text] [Related]  

  • 64. Lower Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir in Patients With Chronic Hepatitis B.
    Zhang H; Zeng W
    JAMA Oncol; 2019 Jun; 5(6):914-915. PubMed ID: 31021391
    [No Abstract]   [Full Text] [Related]  

  • 65. Lower Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir in Patients With Chronic Hepatitis B.
    Kong Y; Jia J; Yang HI
    JAMA Oncol; 2019 Jun; 5(6):915-916. PubMed ID: 31021371
    [No Abstract]   [Full Text] [Related]  

  • 66. Universal hepatitis B vaccination: The only way to eliminate hepatocellular carcinoma?
    Leroy V; Asselah T
    J Hepatol; 2015 Dec; 63(6):1303-5. PubMed ID: 26450812
    [No Abstract]   [Full Text] [Related]  

  • 67. Lower Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir in Patients With Chronic Hepatitis B-in Reply.
    Choi J; Ko MJ; Lim YS
    JAMA Oncol; 2019 Jun; 5(6):916-917. PubMed ID: 31021372
    [No Abstract]   [Full Text] [Related]  

  • 68. Comparison of the Efficacy of Tenofovir Versus Tenofovir plus Entecavir in the Treatment of Chronic Hepatitis B in Patients With Poor Efficacy of Entecavir: A Systematic Review and Meta-analysis.
    Chen J; Zhao SS; Liu XX; Huang ZB; Huang Y
    Clin Ther; 2017 Sep; 39(9):1870-1880. PubMed ID: 28797777
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients.
    Su TH; Hu TH; Chen CY; Huang YH; Chuang WL; Lin CC; Wang CC; Su WW; Chen MY; Peng CY; Chien RN; Huang YW; Wang HY; Lin CL; Yang SS; Chen TM; Mo LR; Hsu SJ; Tseng KC; Hsieh TY; Suk FM; Hu CT; Bair MJ; Liang CC; Lei YC; Tseng TC; Chen CL; Kao JH;
    Liver Int; 2016 Dec; 36(12):1755-1764. PubMed ID: 27634134
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Long-term outcomes of hepatitis B virus-related cirrhosis treated with nucleos(t)ide analogs.
    Tsai MC; Chen CH; Hu TH; Lu SN; Lee CM; Wang JH; Hung CH
    J Formos Med Assoc; 2017 Jul; 116(7):512-521. PubMed ID: 27720344
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Head-To-Head Comparison of Two Years Efficacy of Entecavir and Tenofovir in Patients with Treatment-Naïve Chronic Hepatitis B--The Real Life Data.
    Hepatogastroenterology; 2015 Jun; 62(140):982-6. PubMed ID: 26902041
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Management and treatment of patients with hepatitis B].
    den Eynde EV; Riveiro-Barciela M
    Enferm Infecc Microbiol Clin; 2016 Jul; 34 Suppl 3():47-51. PubMed ID: 27474247
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Tenofovir vs Entecavir for Hepatocellular Carcinoma Prevention in Patients With Chronic Hepatitis B: One of These Things Is Not Like the Other.
    Flemming JA; Terrault NA
    JAMA Oncol; 2019 Jan; 5(1):17-18. PubMed ID: 30267036
    [No Abstract]   [Full Text] [Related]  

  • 74. A meta-analysis comparing the efficacy of entecavir and tenofovir for the treatment of chronic hepatitis B infection.
    Zuo SR; Zuo XC; Wang CJ; Ma YT; Zhang HY; Li ZJ; Song LY; Deng ZZ; Liu SK
    J Clin Pharmacol; 2015 Mar; 55(3):288-97. PubMed ID: 25293471
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Nucleos(t)ide Analogues for Reducing Hepatocellular Carcinoma in Chronic Hepatitis B Patients: A Systematic Review and Meta-Analysis.
    Wang X; Liu X; Dang Z; Yu L; Jiang Y; Wang X; Yan Z
    Gut Liver; 2020 Mar; 14(2):232-247. PubMed ID: 31158948
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Tenofovir-best hope for treatment of chronic hepatitis B infection?
    Örmeci N; Özbaş B; Güner R; Özkan H; Yalçı A; Çoban Ş; Dökmeci A; Kalkan Ç; Akıncı H; Yüksel O; Başar Ö; Yüksel İ; Balık İ
    Turk J Gastroenterol; 2015 Jul; 26(4):322-7. PubMed ID: 26038999
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Hepatocellular carcinoma risk in HBeAg-negative chronic hepatitis B patients with or without cirrhosis treated with entecavir: HepNet.Greece cohort.
    Papatheodoridis GV; Manolakopoulos S; Touloumi G; Nikolopoulou G; Raptopoulou-Gigi M; Gogos C; Vafiadis-Zouboulis I; Karamanolis D; Chouta A; Ilias A; Drakoulis C; Mimidis K; Ketikoglou I; Manesis E; Mela M; Hatzis G; Dalekos GN;
    J Viral Hepat; 2015 Feb; 22(2):120-7. PubMed ID: 25040685
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Comparison of the efficacy of entecavir and tenofovir in chronic hepatitis B.
    Güzelbulut F; Ovünç AO; Oetinkaya ZA; Senates E; Gökden Y; Saltürk AG; Sezikli M; Ozkara S; Cetinkaya F
    Hepatogastroenterology; 2012; 59(114):477-80. PubMed ID: 21940383
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Comparison of risk of hepatocellular carcinoma between tenofovir and entecavir: One direction or no direction.
    Choi J; Lim YS
    J Hepatol; 2019 Oct; 71(4):846-847. PubMed ID: 31351769
    [No Abstract]   [Full Text] [Related]  

  • 80. Effects of radiofrequency ablation combined with transarterial chemoembolization and antiviral therapy on the prognosis and quality of life in primary chronic HBV-related liver cancer.
    Lu B; Zhu L; Wang X; Zhong L; Cheng Y; Fan J; Yu L
    J BUON; 2019; 24(5):1979-1984. PubMed ID: 31786864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.